PDE4DIP and breast cancer: Onyeisi et al. pointed out that in breast cancer, the most common malignancy in women, the abnormal expression of syndecan-4 is affected by transcriptional and post-transcriptional mechanisms, including PDE4DIP gene mutations [11].